<?xml version='1.0' encoding='utf-8'?>
<document id="20463004"><sentence text="Furanocoumarin derivatives in Kampo extract medicines inhibit cytochrome P450 3A4 and P-glycoprotein."><entity charOffset="0-14" id="DDI-PubMed.20463004.s1.e0" text="Furanocoumarin" /></sentence><sentence text="Furanocoumarins in grapefruit are known to show inhibitory effects against P-glycoprotein (P-gp) and CYP3A4 in intestinal epithelial cells; however, furanocoumarin derivatives are widely contained in the plants of Rutaceae and Umbelliferae families, which are used as components of Kampo extract medicines"><entity charOffset="149-163" id="DDI-PubMed.20463004.s2.e0" text="furanocoumarin" /></sentence><sentence text=" In this study, we investigated the inhibitory effects of 12 furanocoumarins extracted from plants in the Umbelliferae family against P-gp and CYP3A4 activity" /><sentence text=" Furthermore, we studied their inhibitory effect on P-gp when furanocoumarins are used as Kampo extract medicine rather than as an isolated single compound" /><sentence text=" From screening of the CYP3A4 inhibitory effect, notopterol and rivulobirin A, the only dimer types of furanocoumarin, were found to be potent inhibitors of CYP3A4"><entity charOffset="49-59" id="DDI-PubMed.20463004.s5.e0" text="notopterol" /><entity charOffset="64-77" id="DDI-PubMed.20463004.s5.e1" text="rivulobirin A" /><entity charOffset="103-117" id="DDI-PubMed.20463004.s5.e2" text="furanocoumarin" /><pair ddi="false" e1="DDI-PubMed.20463004.s5.e0" e2="DDI-PubMed.20463004.s5.e0" /><pair ddi="false" e1="DDI-PubMed.20463004.s5.e0" e2="DDI-PubMed.20463004.s5.e1" /><pair ddi="false" e1="DDI-PubMed.20463004.s5.e0" e2="DDI-PubMed.20463004.s5.e2" /><pair ddi="false" e1="DDI-PubMed.20463004.s5.e1" e2="DDI-PubMed.20463004.s5.e1" /><pair ddi="false" e1="DDI-PubMed.20463004.s5.e1" e2="DDI-PubMed.20463004.s5.e2" /></sentence><sentence text=" On the other hand, byakangelicol and rivulobirin A showed strong P-gp inhibition from the screening of P-gp inhibitor evaluated by quinidine permeation through the Caco-2 monolayer; however, the chemical structural relationship of furanocoumarins between P-gp and CYP3A4 inhibitory effects could not be obtained"><entity charOffset="20-33" id="DDI-PubMed.20463004.s6.e0" text="byakangelicol" /><entity charOffset="38-51" id="DDI-PubMed.20463004.s6.e1" text="rivulobirin A" /><entity charOffset="132-141" id="DDI-PubMed.20463004.s6.e2" text="quinidine" /><pair ddi="false" e1="DDI-PubMed.20463004.s6.e0" e2="DDI-PubMed.20463004.s6.e0" /><pair ddi="false" e1="DDI-PubMed.20463004.s6.e0" e2="DDI-PubMed.20463004.s6.e1" /><pair ddi="false" e1="DDI-PubMed.20463004.s6.e0" e2="DDI-PubMed.20463004.s6.e2" /><pair ddi="false" e1="DDI-PubMed.20463004.s6.e1" e2="DDI-PubMed.20463004.s6.e1" /><pair ddi="false" e1="DDI-PubMed.20463004.s6.e1" e2="DDI-PubMed.20463004.s6.e2" /></sentence><sentence text=" We also investigated the effect of these furanocoumarins on the transport of digoxin through the Caco-2 monolayer"><entity charOffset="78-85" id="DDI-PubMed.20463004.s7.e0" text="digoxin" /></sentence><sentence text=" The inhibitory effect of rivulobirin A was more potent than that of byakangelicol"><entity charOffset="26-39" id="DDI-PubMed.20463004.s8.e0" text="rivulobirin A" /><entity charOffset="69-82" id="DDI-PubMed.20463004.s8.e1" text="byakangelicol" /><pair ddi="false" e1="DDI-PubMed.20463004.s8.e0" e2="DDI-PubMed.20463004.s8.e0" /><pair ddi="false" e1="DDI-PubMed.20463004.s8.e0" e2="DDI-PubMed.20463004.s8.e1" /></sentence><sentence text=" Application of either Senkyu-cha-cho-san or Sokei-kakketsu-to, which are composed of herbal remedies in the Umbelliferae group, significantly decreased the efflux ratio of digoxin"><entity charOffset="173-180" id="DDI-PubMed.20463004.s9.e0" text="digoxin" /></sentence><sentence text=" In conclusion, it was found that some furanocoumarins extracted from the plants in the Umbelliferae family strongly inhibited P-gp and CYP3A4"><entity charOffset="39-54" id="DDI-PubMed.20463004.s10.e0" text="furanocoumarins" /></sentence><sentence text=" Kampo extract medicines containing herbal remedies belonging to the Umbelliferae family may cause a drug-drug interaction with P-gp or a CYP3A4 substrate drug" /><sentence text="" /></document>